ARCHIVES

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

News Analysis: Filing Will Ignite Complex Litigation Costing Millions, With Uncertain Rewards

March 9, 2012

NCAB Okays Funding Core Grants For ICC, Hawaii, UC-San Diego

February 15, 1985

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

Animas As Early Warning “Sentinels” Part Of DCE Study

July 31, 1987

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982